Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy
Abstract Membranous nephropathy (MN) and minimal change disease (MCD) are two common causes leading to nephrotic syndrome (NS). They have similar clinical features but different treatment strategies and prognoses. M-type phospholipase A2 receptor (PLA2R) is considered as a specific marker of membran...
Saved in:
| Main Authors: | Feng Wu, Yiding Zhang, Wen Cui, Yijun Dong, Yingyang Geng, Changhao Liu, Zemeng Li, Yandong Xie, Xiaojing Cai, Jin Shang, Jing Xiao, Zhanzheng Zhao |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/1136edcd8ec746dab3179c01bccfa05c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
by: Lyle W. Baker, et al.
Published: (2021) -
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
by: Natasha Honoré, et al.
Published: (2021) -
Discrimination of Chronic Kidney Disease and Diabetic Nephropathy and Analysis of Their Related Influencing Factors
by: Liu X, et al.
Published: (2020) -
Identification of a two-SNP PLA2R1 Haplotype and HLA-DRB1 Alleles as Primary Risk Associations in Idiopathic Membranous Nephropathy
by: Khun Zaw Latt, et al.
Published: (2018) -
Clinical manifestations of focal segmental glomerulosclerosis in Japan from the Japan Renal Biopsy Registry: age stratification and comparison with minimal change disease
by: Takaya Ozeki, et al.
Published: (2021)